After Toby Keith’s death, doctors warn that stomach cancer ... - NBC News
Feb 6, 2024 · Country star Toby Keith died Monday at 62, more than 2 years after being diagnosed with stomach cancer. Doctors say common signs include heartburn or acid reflux.
New heated drug baths provide hope for patients with stomach cancer
Apr 4, 2024 · Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with stomach cancer and peritoneal metastasis, which is cancer that has spread to the lining of the abdominal cavity.
New Gastric & Esophageal Cancer Treatment Breakthrough
Mar 23, 2022 · There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.
Metastatic Stomach Cancer: New Treatment to Be Approved - Healthline
Nov 28, 2023 · Zolbetuximab is a new drug for the treatment of gastric cancer. In trials, it showed significant improvement in survival rates. The FDA is expected to make an approval decision on the drug in...
Targeted treatment shows promise for stomach cancer
Aug 24, 2023 · An international phase 3 clinical trial found that a new targeted treatment, given in combination with a standard chemotherapy, extended survival for select patients with advanced gastric or gastroesophageal junction cancer.
Changes to Treatment for HER2-Positive Gastric Cancer - NCI
Nov 17, 2023 · On November 16, a week after amending its approval for HER2-positive disease, the Food and Drug Administration (FDA) approved pembrolizumab combined with chemotherapy as an initial treatment for people with advanced stomach (gastric) or gastroesophageal junction (GEJ) cancer that is HER2-negative.
Gastric cancer - Latest research and news | Nature
2 days ago · Gastric cancer, or stomach cancer, is a type of cancer that begins in the mucus-producing cells on the inside lining of the stomach. The most common type of stomach cancer is adenocarcinoma.
Groundbreaking research offers early clues to stomach cancer ...
Dec 11, 2023 · In a breakthrough study published in the journal Cancer Cell, researchers have decoded critical genetic factors in intestinal metaplasia patients, shedding light on early signs and prevention...
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic...
Constanza Camargo Awarded Scientific Tenure by the NIH
2 days ago · In December, Dr. Constanza Camargo was awarded scientific tenure by the NIH and promoted to senior investigator in the Metabolic Epidemiology Branch (MEB). Dr. Camargo is an internationally recognized expert on the epidemiology of gastric cancer, an understudied malignancy with high mortality coupled with substantial economic and social costs.